Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
Abrahami D, Douros A, Yin H, et al.
BMJ. 2018;363:k4880
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Abrahami D, Douros A, Yin H, et al.
BMJ. 2018;363:k4880
Leggi
Schernthaner G, Schernthaner-Reiter MH
The Lancet Diabetes and Endocrinology. Published online, 5 December 2018
Leggi
Svanström H, Ueda P, Melbye M, et al.
The Lancet Diabetes and Endocrinology. Published online, 5 December 2018
Leggi
Dodd JM, Louise J, Deussen AR, et al.
The Lancet Diabetes and Endocrinology. Published online, 4 December 2018
Leggi
Harding JL, Pavkov ME, Magliano DJ, et al.
Diabetologia. 2019;62(1):3-16
Leggi
Zhang T, Xu J, Li S, et al.
Diabetologia. 2019;62(1):70-7
Leggi
Gæde J, Oellgaard J, Ibsen R, et al.
Diabetologia. 2019,62(1):147-55
Leggi
Landi SN, Radke S, Engel SM, et al.
JAMA Pediatr. Published online, 3 December 2018.
Leggi
Huynh T, Harty BJ, Claggett B, et al.
The American Journal of Cardiology. Published online, 24 November 2018.
Leggi
Patterson CC, Harjutsalo V, Rosenbauer J, et al.
Diabetologia. Published online, 28 November 2018.
Leggi